Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02327078
Title A Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation

lung non-small cell carcinoma

head and neck squamous cell carcinoma

diffuse large B-cell lymphoma

non-Hodgkin lymphoma


ovarian cancer

colorectal cancer

Hodgkin's lymphoma



Epacadostat + Nivolumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.